Abstract:Background: Increasing evidence has suggested that dysregulation of microRNAs (miRNAs) could contribute to human disease including cancer. Previous miRNA microarray analysis illustrated that miR-320c is down-regulated in various cancers. However, the roles of miR-320c in human bladder cancer have not been well elucidated. Therefore, this study was performed to investigate the biological functions and molecular mechanisms of miR-320c in human bladder cancer cell lines, discussing whether it could be a therapeutic biomarker of bladder cancer in the future. Methods: Two human bladder cancer cell lines and samples from thirteen patients with bladder cancer were analyzed for the expression of miR-320c by quantitative RT-PCR. Over-expression of miR-320c was established by transfecting mimics into T24 and UM-UC-3. Cell proliferation and cell cycle were assessed by cell viability assay, flow cytometry and colony formation assay. Cell motility ability was evaluated by transwell assay. The target gene of miR-320c was determined by luciferase assay, quantitative RT-PCR and western blot. The regulation of cell cycle and mobility by miR-320c was analyzed by western blot. Results: We observed that miR-320c was down-regulated in human bladder cancer tissues and bladder cancer cell lines T24 and UM-UC-3. Over-expression of miR-320c could induce G1 phase arrest in UM-UC-3 and T24 cells, and subsequently inhibited cell growth. We also indentified miR-320c could impair UM-UC-3 and T24 cell motility. In addition, we identified CDK6, a cell cycle regulator, as a novel target of miR-320c. Moreover, we demonstrated miR-320c could induce bladder cancer cell cycle arrest and mobility via regulating CDK6. We also observed that inhibition of miR-320c or restoration of CDK6 in miR-320c-over-expressed bladder cancer cells partly reversed the suppressive effects of miR-320c. Conclusions: miR-320c could inhibit the proliferation, migration and invasion of bladder cancer cells via regulating CDK6. Our study revealed that miR-320c could be a therapeutic biomarker of bladder cancer in the future.

Down-regulation of the Cyclin E1 Oncogene Expression by Microrna-16-1 Induces Cell Cycle Arrest in Human Cancer Cells.

Systematic Validation of Predicted Micrornas for Cyclin D1

MiR-15a is Underexpressed and Inhibits the Cell Cycle by Targeting CCNE1 in Breast Cancer

MiR-129-5p Induces Cell Cycle Arrest Through Modulating HOXC10/Cyclin D1 to Inhibit Gastric Cancer Progression.

Mir-2861 Acts As a Tumor Suppressor Via Targeting EGFR/AKT2/CCND1 Pathway in Cervical Cancer Induced by Human Papillomavirus Virus 16 E6

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

A Cyclin D 1 / Microrna 17 / 20 Regulatory Feedback Loop in Control of Breast Cancer Cell Proliferation

MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer

Down-regulation of Microrna-135B Inhibited Growth of Cervical Cancer Cells by Targeting FOXO1.

MicroRNA-188 Suppresses G 1 /S Transition by Targeting Multiple Cyclin/cdk Complexes

Mir-497 and Mir-34A Retard Lung Cancer Growth by Co-Inhibiting Cyclin E1 (CCNE1)

MicroRNA-15b Regulates Cell Cycle Progression by Targeting Cyclins in Glioma Cells.

Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region

MicroRNA-372 Is Down-regulated and Targets Cyclin-dependent Kinase 2 (CDK2) and Cyclin A1 in Human Cervical Cancer, Which May Contribute to Tumorigenesis

Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1.

MicroRNA-320c Inhibits Tumorous Behaviors of Bladder Cancer by Targeting Cyclin-dependent Kinase 6

Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2

Mirna-30A Functions As a Tumor Suppressor by Downregulating Cyclin E2 Expression in Castration-Resistant Prostate Cancer.

c-Myc-regulated microRNAs modulate E2F1 expression

Mir-195 Inhibits the Proliferation of Human Cervical Cancer Cells by Directly Targeting Cyclin D1

Microrna-141 Inhibits Tumor Growth and Minimizes Therapy Resistance in Colorectal Cancer